Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
Exp Toxicol Pathol
; 58(6): 375-82, 2007 Aug.
Article
en En
| MEDLINE
| ID: mdl-17408938
ABSTRACT
To evaluate new-drugs potential for phospholipidosis (PL), we developed a cell-based fluorescence assay using a fluorescent-labeled phospholipid analogue (NBD-PE). CHL/IU cells derived from newborn hamster lung were exposed to positive reference compounds (amiodarone, imipramine, chloroquine, propranolol, chlorpromazine and amantadine) in the presence of NBD-PE, and the level of PL, as indicated by accumulation of fluorescent inclusions in the cytoplasm, was evaluated using fluorescence microscopy and fluorometry. All positive reference compounds induced accumulation of fluorescent inclusions in a concentration-dependent manner with an increase in fluorescence intensity. Fluorescence microscopically, the positive dose of test compound was determined as the concentration with a grade equivalent to or above that of 3.13 microM of amiodarone. Based on this criterion, 8 of 20 test compounds including PL-positive or -negative compounds were judged positive that were concurrent with the pathological results from rat toxicity studies. Furthermore, a positive criterion for fluorometry was decided as equivalent to or above 25% of maximum intensity induced by 1.56-25.0 microM amiodarone. In comparison of fluorometry methods with fluorescence microscopy method, 19 of 20 compounds were judged same. From these findings, we concluded that the assay developed in this study is a rapid and reliable method to predict new-drugs potential for PL at an early stage of drug development.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Fosfatidiletanolaminas
/
Fosfolípidos
/
Evaluación Preclínica de Medicamentos
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Colorantes Fluorescentes
/
Lipidosis
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Exp Toxicol Pathol
Año:
2007
Tipo del documento:
Article
País de afiliación:
Japón